Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine and Lactobacillus casei in Symptomatic Uncomplicated Diverticular Disease
NCT01534754Phase 4Completed
- Sponsor
- Ospedale Cristo Re
- Start
- Jan 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Salcrozine, lactobacillus casei in diverticular disease, sponsored by Ospedale Cristo Re. Started Jan 2009; status: completed.
02
Drugs
Salcrozinelactobacillus casei
03
Conditions
diverticular disease
Beyond the preview
Go deeper on NCT01534754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534754.